Pemafibrate Prevents Retinal Pathological Neovascularization by Increasing FGF21 Level in a Murine Oxygen-Induced Retinopathy Model

Large-scale clinical trials, such as the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) and the Action to Control Cardiovascular Risk in Diabetes (ACCORD) studies, have shown that the administration of fenofibrate, a peroxisome proliferator-activated receptor alpha (PPARα) agonist,...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomita, Yohei, Ozawa, Nobuhiro, Miwa, Yukihiro, Ishida, Ayako, Ohta, Masayuki, Tsubota, Kazuo, Kurihara, Toshihide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928689/
https://www.ncbi.nlm.nih.gov/pubmed/31771164
http://dx.doi.org/10.3390/ijms20235878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928689/
https://www.ncbi.nlm.nih.gov/pubmed/31771164
http://dx.doi.org/10.3390/ijms20235878

Ejemplares similares